1. 1. Nakamura S. The actual condition of medical examination: drymouth. Jpn J Clinical and Experimental Medicine 2007; 84:939-946. (in Japanese)
2. 2. Akizuki M. Sjögren’s syndrome. Jpn Med J 1992; 3542:30-34. (in Japanese)
3. 3. Arisawa H, Imai E, Fujise N, Fukui K, and Masunaga H. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren’s syndrome. Arzneim.-Forsch./Drug Res 2002; 52:14-20.
4. 4. Kashiwazaki S, Ichikawa Y, Torikai K, Kondo H, Miyawaki S et al. Examination of the dose increase method about the effectiveness and the safety of SNI-2011 against drymouth in sjögren’s syndrome patients. Med Consult New Remedies 2001; 38:313-332. (in Japanese).
5. 5. Ichikawa Y, Kashiwazaki S, Hara M, Torikai K, Kondo H et al. Double-blind test competitive examination between SNI-2011 and placebo against drymouth in sjögren’s syndrome patients. Med Consultation and New Remedies 2001; 38:349-368. (in Japanese).